Cell Cycle
-
NSC 663284
Catalog No. A13524 Cdc25 抑制剂NSC 663284是所有Cdc25同工型的有效,细胞可渗透且不可逆的抑制剂,首选Cdc25A(对于Cdc25A,Cdc25B2和Cdc25C,IC50分别为29、95和89 nM)。 了解更多 -
CDK9 inhibitor 2
Catalog No. A15039 -
AT7519 trifluoroacetate
Catalog No. A15005 CDK 抑制剂AT7519 trifluoroacetate是CDK1、2、4、6和9的多CDK抑制剂,IC50为10-210 nM,对CDK3的效力较低,对CDK7的活性较低。 了解更多 -
RGB-286638
Catalog No. A13130 CDK 抑制剂RGB-286638是一种新型CDK抑制剂,对于细胞周期蛋白T1-CDK9/细胞周期蛋白B1-CDK1/细胞周期蛋白E-CDK2/细胞周期蛋白D1-CDK4/细胞周期蛋白E-CDK3的IC50为1 nM/2 nM/3 nM/4 nM/5 nM/p35-CDK5分别;对细胞周期蛋白H-CDK7和细胞周期蛋白D3-CDK6的效力较低。 了解更多 -
Bohemine
Catalog No. A15942 -
LY2835219 methanesulfonate
Catalog No. A16386 -
SB1317 (TG02)
Catalog No. A13454 CDK/JAK2/FLT3 抑制剂SB1317是细胞周期蛋白依赖性激酶(CDKs)、类FMS酪氨酸激酶-3(FLT3)和Janus激酶2(JAK2)的有效抑制剂,CDK2、JAK2和FLT3的IC50值分别为13nM、56nM和73nM。 了解更多 -
Atuveciclib (BAY-1143572)
Catalog No. A16810 Selective PTEFb/CDK9 抑制剂Atuveciclib (BAY-1143572)是目前处于I期的PTEFb/CDK9的高度选择性,有效且可口服的抑制剂。 了解更多 -
ICEC0942 HCl
Catalog No. A16903 CDK7 抑制剂ICEC0942 HCl,也称为CT7001,是CDK7的口服生物利用选择性抑制剂。它选择性抑制CDK7,IC50为40nM。CDK1,CDK2,CDK5和CDK9的IC50值分别高45倍,15倍,230倍和30倍。 了解更多 -
PF-06873600
Catalog No. A16875 CDK 抑制剂PF-06873600是一种口服生物利用型,细胞周期蛋白依赖性激酶(CDK)抑制剂,其对 CDK2、CDK4和CDK6的Ki值分别为 0.09 nM、0.13 nM 和 0.16 nM。具有潜在的抗肿瘤活性。 了解更多 -
SEL120-34A
Catalog No. A17086 -
Trilaciclib
Catalog No. A17084 -
Lerociclib (G1T38)
Catalog No. A18320 CDK inhibitorLerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 1 nM, 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively. 了解更多 -
CDK4/6-IN-2
Catalog No. A18657 CDK4/CDK6 inhibitorCDK4/6-IN-2 is a potent CDK4 and CDK6 inhibitor with IC50s of 2.7 and 16 nM for CDK4 and CDK6, respectively. 了解更多 -
THAL-SNS-032
Catalog No. A19088 CDK9 degrader PROTACTHAL-SNS-032 is a selective CDK9 degrader PROTAC consisting of a CDK-binding SNS-032 ligand linked to a thalidomide derivative that binds the E3 ubiquitin ligase Cereblon (CRBN). 了解更多 -
FMF-04-159-2
Catalog No. A18911 CDK14 inhibitorFMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively. 了解更多 -
Abemaciclib Metabolites M2
Catalog No. A18416 CDK4/CDK6 inhibitorAbemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s in the range of 1-3 nM. Anti-cancer activity. 了解更多 -
MSC2530818
Catalog No. A12644 CDK8 inhibitorMSC2530818 is a potent, selective and orally available CDK8 inhibitor with an IC50 of 2.6 nM for CDK8. 了解更多 -
Ca2+ channel agonist 1
Catalog No. A12186 Ca2+ channel agonist/CDK2 inhibitorCa2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2, with EC50s of 14.23 μM and 3.34 μM, respectively, and is used as a potential treatment for motor nerve terminal dysfunction. 了解更多 -
MLN8237 (Alisertib)
Catalog No. A10004 Aurora A Kinase 抑制剂MLN8237 (Alisertib)是一种选择性Aurora A抑制剂,在无细胞分析中的IC50为1.2 nM。它对Aurora A的选择性比Aurora B高200倍以上。 了解更多 -
AZD1152-HQPA (Barasertib)
Catalog No. A10109 Aurora Kinase B 抑制剂AZD1152-HQPA (Barasertib)是Aurora B的高效抑制剂,Ki值分别为0.36(Aurora B)和1369 nM(Aurora A),与一组其他50种激酶相比具有很高的特异性。 了解更多 -
VX-680 (MK-0457, Tozasertib)
Catalog No. A10981 Aurora Kinase 抑制剂VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。 了解更多 -
MK-5108 (VX-689)
Catalog No. A11410 Aurora A Kinase 抑制剂MK-5108,也称为VX-689,是Aurora A激酶ATP结合位点的竞争性抑制剂。 了解更多 -
Hesperadin
Catalog No. A10448 Aurora B Kinase 抑制剂Hesperadin是一种人极光B抑制剂,IC50为40 nM,用于防止底物磷酸化。它显著降低AMPK、Lck、MKK1、MAPKAP-K1、CHK1和PHK的活性,而不抑制MKK1在体内的活性。 了解更多 -
Danusertib (PHA-739358)
Catalog No. A10715 Aurora 抑制剂Danusertib (PHA-739358)是Aurora A/B/C的Aurora激酶抑制剂,在无细胞分析中的IC50为13 nM/79nM/61 nM,对Abl,TrkA,c-RET和FGFR1以及更低的浓度具有中等效力 对Lck,VEGFR2/3,c-Kit,CDK2等有效。 了解更多